COEP
Coeptis Therapeutics·NASDAQ
--
--(--)
--
--(--)
COEP Filings
Filing Date
Form Description
Form Type
2026-01-05
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-05 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-29
Form EFFECT - Notice of Effectiveness
2025-12-29 ·
Form EFFECT - Notice of Effectiveness
2025-12-22
Form S-4/A - Registration of securities, business combinations: [Amend]
Key Events
2025-12-22 · Key Events
Form S-4/A - Registration of securities, business combinations: [Amend]
2025-12-15
Form 144 - Report of proposed sale of securities
Ownership
2025-12-15 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-10
Form S-4/A - Registration of securities, business combinations: [Amend]
Key Events
2025-12-10 · Key Events
Form S-4/A - Registration of securities, business combinations: [Amend]
2025-11-14
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-14 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-14
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-14 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-14
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-14 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-03
Form S-4/A - Registration of securities, business combinations: [Amend]
Key Events
2025-10-03 · Key Events
Form S-4/A - Registration of securities, business combinations: [Amend]
